secwatch.observer — SEC 8-K summary
======================================

Issuer:     DMK PHARMACEUTICALS Corp (—)
CIK:        0000887247
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001387131-23-012033
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DMK Pharmaceuticals receives Nasdaq delisting notice for bid price non-compliance
--------------------------------------------------------------------------------

- Received Nasdaq notice on Oct 4, 2023 for failing $1.00 minimum bid price (Rule 5550(a)(2)).
- 180-day compliance period until April 1, 2024; must close at $1.00+ for 10 consecutive days.
- If not cured, may be eligible for an additional 180-day period if other listing standards are met.
- Company will monitor bid price and consider available options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887247/000138713123012033/0001387131-23-012033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887247/000138713123012033/dmk-8k_100423.htm
  HTML page:      https://secwatch.observer/filing/0001387131-23-012033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer